OBJECTIVE: Pharmacologic agents designed to promote mucociliary clearance (MCC) in chronic rhinosinusitis (CRS) represent a novel therapeutic strategy. The objectives of the present study were to investigate whether the natural bioflavonoid hesperidin 1) increases transepithelial chloride (Cl -) secretion in vitro and in vivo, 2) enhances ciliary beat frequency (CBF), and 3) exerts its mechanistic effects through cAMP/PKA-dependent pathways. STUDY DESIGN: In vitro and in vivo study. SETTING: Laboratory. SUBJECTS AND METHODS: Transepithelial Cltransport (Ussing chamber) and CBF were investigated in primary murine nasal septal (MNSE) and human sinonasal epithelial (HSNE) cultures. In vivo activity was measured using the murine nasal potential difference (NPD) assay, cystic fibrosis transmembrane conductance regulator (CFTR) R-domain phosphorylation, and cAMP levels were investigated to rule out a cAMP/PKA-dependent mechanism of activation. RESULTS: Hesperidin significantly increased CFTR-mediated Cltransport (change in short-circuit current, ⌬I SC ) in both MNSE (13.51 Ϯ 0.77 vs 4.4 Ϯ 0.66 [control]; P Ͻ 0.05) and HSNE (12.28 Ϯ 1.08 vs 0.69 Ϯ 0.32 [control]; P Ͻ 0.05). Cltransport across in vivo murine nasal epithelium was also significantly enhanced with hesperidin (-2.3 Ϯ 1.0 vs -0.8 Ϯ 0.8 mV [control], P Ͻ 0.05). There was no increase in cellular cAMP or phosphorylation of the CFTR R-domain. Hesperidin significantly increased CBF (ratio of pretreatment to post-treatment) with both basal (1.31 Ϯ 0.07 vs 0.93 Ϯ 0.06 [control]; P Ͻ 0.05), apical (1.72 Ϯ 0.09 vs 1.40 Ϯ 0.07 [control]; P Ͻ 0.05), and basal ϩ apical delivery (2.26 Ϯ 0.18 vs 1.60 Ϯ 0.21, respectively; P Ͻ 0.05). CONCLUSION: Our in vitro and in vivo investigations provide strong support for future testing of this robust Clsecretagogue and CBF activator in human clinical trials for CRS.
I neffective mucociliary clearance (MCC) is a common pathophysiologic process present in airway inflammation and infection. Airway surface liquid (ASL) is a principal component of the mucociliary apparatus and is strongly influenced by the vectorial transport of ions, such as chloride (Cl -). 1 Dysfunctional Cltransport results in dehydration of the ASL and mucus stasis as demonstrated in the severe lower and upper respiratory disease cystic fibrosis (CF). Patients with inspissated mucus are at high risk for bacterial infection and widespread chronic rhinosinusitis (CRS) refractory to medical management. Conventional interventions for CRS have been limited by bacterial resistance incurred with antibiotic overuse and the deleterious side effects of steroids. Safe but effective compounds that enhance Cltransport, specifically those that activate the cystic fibrosis transmembrane conductance regulator (CFTR), could provide significant therapeutic advantages in this regard.
Recent drug discovery efforts have identified several exciting small molecules that activate or potentiate CFTR 2, 3 for treatment of CF and other respiratory diseases. CFTR has two transmembrane domains, two nucleotide binding domains (NBDs), and a regulatory domain (R-D). Activation of CFTR Cltransport requires phosphorylation of the R-D by cAMP/PKA-dependent pathways, as well as heterodimerization of the two NBDs 4 (Fig 1) . Drugs that either activate (phosphorylate the R-D) or potentiate (increase channel open time) are desirable and continue to be an active area of laboratory and clinical investigation in airway disease. This strategy has shown significant clinical promise in CF and has been highly visible in both the scientific 5 and lay communities 6 over the past year. However, the same strategy clearly activates Clsecretion in the nasal as well as lower airways, and therefore may benefit subjects with CRS and impaired sinonasal MCC. 7 Using CFTR activators as a therapeutic intervention in CRS has not been investigated previously, and thus represents a new and leading-edge approach to treatment.
Flavonoids are among the most potent activators of CFTR gating, 8, 9 and are excellent candidates for restoring and/or increasing CFTR activity in sinus and nasal epithelium. Flavonoids are a group of ubiquitous plant molecules (based on the backbone of 2-phenylchromen-4-one) (Fig 1) that exhibit a number of biological effects critical to human health, and have been shown previously to confer antibacterial, antiviral, anti-inflammatory, and anti-allergic effects. 8 The flavonoid hesperidin has been investigated as a therapeutic intervention for a wide spectrum of human diseases, including high cholesterol (via impairment in high-density lipoprotein, low-density lipoprotein, triglycerides, and total lipids), 10 inflammation (hesperidin blocks synthesis of proinflammatory arachidonic acid derivatives, including prostaglandins E 2 and F 2 and thromboxane A 2 ) , 11 and cancer (the compound inhibits 4-nitroquinoline 1-oxide, a known carcinogen). 12 However, hesperidin and other glycosylated flavonoids were previously reported to have poor Clsecretory activity in a colonic cell line. 13 In this article, we present evidence that hesperidin is a robust Clsecretagogue (via CFTR) and ciliary beat frequency (CBF) activator in sinonasal epithelium, and therefore represents an excellent candidate for investigating the mechanisms underlying CRS and as part of therapeutic development.
Methods

University of Alabama at Birmingham Institutional Animal
Care and Use Committee and Institutional Review Board approval were obtained prior to initiation of the study.
Cell Culture
Cultures were developed from primary murine nasal septal epithelium (MNSE) and human sinonasal epithelium (HSNE) as previously described. [14] [15] [16] [17] [18] Cultures with well-differentiated, beating cilia and transepithelial resistances (R t ) Ͼ 500 ⍀/cm 2 were mounted in Ussing chambers for short-circuit current (I SC ) measurements or monitored for ciliary beat frequency as described below.
Figure 1
Pharmacologic manipulation of ion transport and ciliary activation pathways. Activators (forskolin, hesperidin) are indicated by the blue arrows, inhibitors by the red arrows (amiloride, INH-172). The structure of hesperidin is noted in the inset; the (2,3-dihydro-2-phenylchromen-4-one) nucleus of a flavone is shown in black. Ciliary beat frequency (CBF) and cystic fibrosis transmembrane conductance regulator (CFTR) are activated through the PKA-dependent pathway. Hesperidin is thought to act as a CFTR channel potentiator through its interactions with the nucleotide binding domains (NBD) rather than activation (phosphorylation) of the regulatory domain (R-D). 8 Hesperidin also stimulates CBF through either localized changes in the composition of the periciliary fluid or an unknown mechanism that confers direct activation.
Insert Summary
A total of 97 MNSE and 12 HSNE cell cultures were used in the completion of these studies. Cultures with transepithelial resistances (R t ) Ͼ 500 ⍀/cm 2 were used to obtain Ussing chamber measurements and monitor ciliary beating with an inverted microscope. A minimum of five wells were used per condition.
Electrophysiology
Solutions and chemicals. The bathing solution contained (in mM) 120 NaCl, 25 NaHCO 3 , 3.3 KH 2 PO 4 , 0.8 K 2 Short-circuit (I SC ) measurements. Transwell inserts (Costar; Corning Inc., Lowell, MA) were mounted in Ussing chambers in order to investigate pharmacologic manipulation of vectorial ion transport. Monolayers were continuously monitored under short-circuit conditions following fluid resistance compensation using automatic voltage clamps (VCC 600; Physiologic Instruments, San Diego, CA). Batch solutions for the transwell filters were warmed to 37°C, and each solution continuously gas lifted with a 95 percent O 2 -five percent CO 2 mixture. DMSO control solutions were tested for comparison. The I SC was assessed at one current measurement per second. By convention, a positive deflection in I SC was defined as the net movement of anions in the serosal to mucosal direction.
Nasal Potential Difference
A three-step protocol was used, as described previously. 19 First, nasal cavities of anesthetized mice (C57/BL6) were perfused sequentially with: 1) Ringer's solution containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, and amiloride 50 M (pH 7.3); 2) amiloride ϩ a low-Cl --containing solution (NMDG, 6 mM Cl -, pH 7.3); and 3) amiloride ϩ low-Cl --containing solution ϩ hesperidin, forskolin 20 mM, or DMSO control. Because of the continuous presence of amiloride (50 M) and the complete replacement of Na ϩ with a membrane-impermeant cation (140 mM NMDG in the perfusion solution), hyperpolarization in this setting is taken to reflect Clsecretion rather than sodium absorption. Each condition was studied for five to 10 minutes until a stable signal was achieved. All traces were interpreted in a masked fashion.
Detection of Regulatory Domain Phosphorylation and cAMP Levels
Because activation of CFTR anion transport requires phosphorylation of the R-D, an ELISA-based detection kit (Cayman Chemicals, Ann Arbor, MI) was used to measure stimulation of cellular cAMP by hesperidin in MNSE cultures, as previously described. 8 To confirm absence of a cAMP/PKA-dependent mechanism, polyclonal NIH-3T3 cells expressing HA-tagged R-domain were treated with hesperidin for 20 minutes and compared to forskolin (100 nM) ϫ five minutes as a positive control and DMSO as negative control. Following lysis, equal amounts (50 g) of total cell lysate were electrophoresed through a 12 percent sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) and immunoblotted with antibody to the HA tag (Covance, Cumberland, VA). Phosphorylation of the R-domain was visualized as a 2-to 4-kD shift in migration, as previously described. 8
Ciliary Beat Frequency
Images were visualized using a 20ϫ objective on an inverted scope (Fisher Scientific, Pittsburgh, PA). Data were captured using a Model A602f-2 Basler area scan highspeed monochromatic digital video camera (Basler AG, Ahrensburg, Germany) at a sampling rate of 100 frames per second and a resolution of 640 ϫ 480 pixels. The Sisson-Ammons Video Analysis (SAVA) 20 system version 2.1.6 was used to analyze each image. For each experiment, a large area of beating cilia was identified. The digital image signal was then routed from the camera directly into an acquisition board (National Instruments, Austin, TX) within a Dell workstation (Dell Inc., Round Rock, TX) running the Windows XP Professional operating system (Microsoft Inc., Redmond, WA). Images were analyzed with virtual instrumentation software for CBF analysis and recordings were made at 200ϫ magnification.
Experiments were all performed at ambient temperature (23°C). Prior to administration of test solution, a baseline recording of CBF was conducted for each cell monolayer, as apical fluid addition alone can increase CBF. Additional fluid depth overlying the respiratory epithelial cell surface stimulates CBF due to improved hydration and enhanced fluid dynamics. Thus, comparison of hesperidin to a phosphatebuffered saline control solution was necessary. Whole-field analysis was performed with each point measured representing one cilia. The reported frequencies (hertz; Hz) describe arithmetic means of these values, followed by standard deviations. Each analysis was normalized to fold change of CBF Hz (treatment/baseline) and the average fold change tested for significance using paired or unpaired t tests as appropriate. A P value Ͻ 0.05 was considered statistically significant.
Statistical Analysis
Statistical analysis was performed using two-tailed unpaired t test and analysis of variance as indicated.
Results
Hesperidin Is a Cl ؊ Secretagogue
Hesperidin exhibited robust stimulation of CFTR-mediated anion transport in a dose-dependent fashion in MNSE cultures (Fig 2) . The highest response was noted at 2.0 mM (⌬I SC , 16.67 Ϯ 0.43 A/cm 2 ), but precipitation was noted with concentrations greater than 1.0 mM, so this dose was considered optimal for the remainder of the studies. Cltransport stimulated by hesperidin (1.0 mM) (⌬I SC , 13.51 Ϯ 0.77 vs 4.4 Ϯ 0.66 [control]; P ϭ 0.000002) was not dependent on pretreatment with the cAMP agonist forskolin, although some baseline activity in the cAMP/PKAdependent pathway is required as the PKA inhibitor H-89 blocks all hesperidin CFTR activation (data not shown).
Total stimulated I SC with the addition of 100 nM forskolin (⌬I SC , 24.93 Ϯ 1.96 vs 18.8 Ϯ 1.96; P ϭ 0.01) and CFTR blockade with INH-172 (⌬I SC , -18.57 Ϯ 1.40 vs -13.27 Ϯ 1.55; P ϭ 0.03) were also significantly different between groups.
Hesperidin Increases Transepithelial Cl -Transport in HSNE
We next sought to determine whether hesperidin activated Clsecretion in HSNE (Fig 3) . Hesperidin had a consistent effect in HSNE, significantly increasing CFTR-dependent Cltransport when compared to DMSO control (⌬I SC , 12.28 Ϯ 1.08 vs 0.69 Ϯ 0.32 [control]; P ϭ 0.000001) (Fig 3) . In addition, total stimulated I SC (⌬I SC , 15.29 Ϯ 1.16 vs 10.62 Ϯ 0.74 [control]; P ϭ 0.007) and CFTR blockade with INH-172 (⌬I SC , -10.52 Ϯ 0.37 vs -8.86 Ϯ 0.40 [control]; P ϭ 0.01) were also significantly different from controls. This model has an overall decreased ion transport phenotype when compared to MNSE. 17 However, hesperidin accounted for a large proportion of the total stimulated CFTR-mediated I SC (80%), because of the minimal additive contribution of forskolin to the ⌬I SC post treatment.
Hesperidin Activates CFTR-Dependent Cl -Conductance across Murine Nasal Epithelium In Vivo
Transepithelial Cltransport measured by the murine NPD assay was also significantly enhanced with hesperidin (-2.3 Ϯ 1.0 mV) when compared to controls (-0.8 Ϯ 0.8 mV, P ϭ 0.04). Hesperidin activation of Cltransport was not significantly different than forskolin (-1.9 Ϯ 1.4 mV, P ϭ 0.65) (Fig 4) .
Hesperidin Activates CFTR Despite No Measurable Effects on cAMP and R-Domain Phosphorylation
PKA/cAMP-dependent phosphorylation of the CFTR Rdomain is a critical step in channel activation, 21 but it also (through an independent mechanism) activates ciliary axonemes to drive stimulated CBF. 22 To examine the basis of CFTR activation and CBF stimulation, we measured the effects of hesperidin on cAMP levels and on R-domain phosphorylation. Hesperidin had no detectable effects on cellular cAMP concentrations (2 mM, 0.60 Ϯ 0.04 pmol/ mL) when compared to DMSO control (0.54 Ϯ 0.09 pmol/ mL) or the marked cAMP elevations demonstrated with forskolin (377.76 Ϯ 19.65 pmol/mL, positive control) ( Fig  5A) . As opposed to the cAMP agonist forskolin, hesperidin also had no detectable effect on recombinant CFTR R-D phosphorylation-dependent mobility shift, findings that together suggest independence from either CFTR or ciliary axoneme phosphorylation ( Fig 5B) . Thus, activation of CFTR and CBF by hesperidin differs from classic cAMPsignaling agonists, and is consistent with a mechanism of action that does not depend upon R-D phosphorylation, as reported with other flavonoid agents including genistein. 23 Hesperidin Increases CBF CBF (measured as fold change over baseline) in MNSE was significantly increased when hesperidin (1 mM) was applied to the basal media (1.31 Ϯ 0.07 vs 0.93 Ϯ 0.06 [control]; P ϭ 0.003) ( Fig 6) . Delivery of the agent to the apical surface also resulted in a significant stimulation of CBF when compared to the control vehicle. Because CBF was also elevated following hesperidin (1.72 Ϯ 0.09 vs 1.40 Ϯ 0.07 [control]; P ϭ 0.01), augmentation of CBF could not solely be attributed to electrolyte and fluid secretion across the apical surface mediated by CFTR. Apical and basal activation by hesperidin was additive in magnitude (2.26 Ϯ 0.18 vs 1.60 Ϯ 0.21, respectively; P ϭ 0.043). When cultures were incubated with the PKA inhibitor H-89 (50 M), there was a significant decrease in CBF compared to hesperidin alone (apical, 1.49 Ϯ 0.15; basal, 1.1 Ϯ 0.18; apical ϩ basal, 1.61 Ϯ 0.20; P ϭ 0.04).
Discussion
Flavonoids are responsible for the autumn colors in tree leaves and the numerous shades of red, yellow, and orange in flowers and food. 24 Fruits, vegetables, stems, flowers, nuts, seeds, herbs, spices, tea, and red wine all contain abundant concentrations of bioflavonoids, with over 4000 structurally unique molecules identified. 25 The compounds display a variety of biological activities, including suppression of inflammation (via inhibition of the NF-B pathway), cancer chemoprevention, and protection from vascular disease, and have had a tremendous safety profile when administered through oral or intravenous means. 26, 27 In the current study, we demonstrated that the bioflavonoid hesperidin (found in citrus fruits) is a robust activa- tor of CFTR-dependent Cltransport in both murine and human primary cell culture models of sinonasal epithelium. Other flavonoids, such as quercetin and genistein, are established activators of CFTR-mediated Cltransport in vitro and in vivo. 2 CFTR, the major Clchannel in the apical membrane of sinonasal respiratory epithelia, mediates fluid and electrolyte transport and is critical to normal ASL homeostasis. While the absence or dysfunction of CFTR results in defective transport and the clinical manifestations of CF, recent evidence indicates that wild-type CFTR processing, endocytic recycling, and function can also be markedly repressed by various environmental insults, including cigarette smoke exposure, high altitude/hypoxemia, inflam-mation, and infectious agents. 18, [28] [29] [30] Thus, CFTR represents a rational therapeutic target for improving MCC in CRS.
Hesperidin exhibited several unique properties in comparison to other flavonoids. While flavonoids have characteristic inhibitory effects at higher concentrations, 2 we did not observe this feature with hesperidin (likely due to decreased solubility at higher concentrations). Furthermore, hesperidin did not maximally activate CFTR in MNSE cultures, but did account for nearly all of the stimulated CFTR-mediated anion transport in HSNE. In contrast to our prior measurements with the flavonoid quercetin (unpublished data), CFTR activation was weaker in MNSE but more active in HSNE, implicating species-dependent effects. While in vivo CFTR stimulation appears comparable to forskolin (according to murine NPD measurements), our in vitro data suggesting hesperidin can stimulate nearly all available CFTR-mediated Cltransport in HSNE will have important implications for future clinical trials.
Experiments with the specific CFTR inhibitor INH-172 demonstrated significant reduction in I SC compared to controls, and indicate that hesperidin exerts its effects through interaction with a CFTR-dependent pathway. Administration of hesperidin (without forskolin) established that pretreatment with an adenylate cyclase activator is not necessary for function of the compound as a Clsecretagogue. However, some basal PKA activity is required for activation of CFTR by hesperidin, since I SC was completely suppressed by the PKA inhibitor H-89. Notably, hesperidin does not increase cellular cAMP and stimulates CFTRmediated Cltransport independent of R-D phosphoryla- tion, indicating that the mechanistic effects of this compound may act through more direct opening of CFTR poreforming elements. Alternatively, an increased driving force for anion secretion through stimulation of basolateral ion transport by hesperidin cannot be excluded. Based on results with other flavonoid agents, our data suggest that the activity of hesperidin may be secondary, at least in part, to direct interaction with CFTR nucleotide binding domains. 23 Channel potentiation measured with membrane patch clamp analysis will be required to confirm this mechanism of action.
The present studies demonstrate that hesperidin also stimulates CBF, a critical component of the mucociliary apparatus. Activation of CBF and Clsecretion are linked by several common cell signaling mechanisms, including fluctuations in cellular cAMP and calcium. 22 While our data indicate that the administration of hesperidin to the basal membrane results in augmented CBF, increased fluid and electrolyte secretion via enhancement of CFTR-mediated Cltransport, resulting in improved ciliary fluid dynamics, are also likely to contribute to the findings described here. The significant increase in CBF may not be attributable strictly to CFTR-dependent fluid secretion, since the fluid meniscus in the epithelial cell culture model is present at a far greater depth than the ASL (up to several mm). Thus, hesperidin also appears to stimulate CBF independent of its ability to increase bulk fluid and electrolyte secretion, perhaps through modulation of periciliary viscosity itself. However, CBF was decreased when incubated with the PKA inhibitor H-89, indicating the majority of effects are secondary to CFTR-mediated hydration of the ASL. While effects on calcium signaling are unlikely, future investigations, including intracellular calcium imaging, are also warranted.
Conclusion
The in vitro and in vivo findings presented here indicate hesperidin is a robust Clsecretagogue and CBF activator in sinonasal epithelium. Our results, coupled with extensive preclinical and clinical experience with this flavonoid reported in the literature, [10] [11] [12] provide strong support for further investigation of this molecule in human clinical trials for CRS.
